Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Highlights: Garofalo Health Care S.p.A.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses: Garofalo Health Care S.p.A.
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company is in debt and has limited leeway for investment
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.